Drug Profile
ZY II
Latest Information Update: 22 Aug 2002
Price :
$50
*
At a glance
- Originator Nonindustrial sources
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 16 Sep 1998 New profile
- 16 Sep 1998 Investigation in HIV infections treatment in China (Unknown route)